These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29323238)

  • 21. Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study.
    Luo J; Chen S; Wang J; Ou S; Zhang W; Liu Y; Qin Z; Xu J; Lu Q; Mo C; Li S; Qin X
    Gene; 2019 Mar; 688():107-118. PubMed ID: 30529247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity.
    Sinha S; Jha GN; Anand P; Qidwai T; Pati SS; Mohanty S; Mishra SK; Tyagi PK; Sharma SK; Venkatesh V; Habib S
    Hum Immunol; 2009 Apr; 70(4):244-50. PubMed ID: 19480840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of L-ficolin levels and FCN2 genotypes with chronic Chagas disease.
    Luz PR; Boldt AB; Grisbach C; Kun JF; Velavan TP; Messias-Reason IJ
    PLoS One; 2013; 8(4):e60237. PubMed ID: 23593180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
    Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
    Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.
    Kumar A; Malaviya AN; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Res; 1994; 13(1):61-71. PubMed ID: 7897264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.
    Zhu XC; Wang HF; Jiang T; Lu H; Tan MS; Tan CC; Tan L; Tan L; Yu JT;
    Mol Neurobiol; 2017 Jan; 54(1):551-562. PubMed ID: 26742530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement receptor 1 single nucleotide polymorphisms in Czech and Dutch patients with sarcoidosis.
    Mrazek F; Kvezereli M; Garr E; Kubistova Z; Kriegova E; Fillerova R; Arakelyan A; Ruven HJ; Drabek J; van den Bosch JM; Kolek V; Welsh KI; Grutters JC; du Bois RM; Petrek M
    Tissue Antigens; 2008 Jan; 71(1):77-80. PubMed ID: 17999656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma.
    Jiao XY; Lü MD; Huang JF; Liang LJ; Shi JS
    World J Gastroenterol; 2004 Dec; 10(23):3480-4. PubMed ID: 15526369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations.
    Kubistova Z; Mrazek F; Lympany PA; Lagan AL; Arakelyan A; Kriegova E; Welsh KI; Kolek V; Zatloukal J; Hutyrova B; du Bois RM; Petrek M
    Tissue Antigens; 2008 Nov; 72(5):483-6. PubMed ID: 18937792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism.
    Hazrati LN; Van Cauwenberghe C; Brooks PL; Brouwers N; Ghani M; Sato C; Cruts M; Sleegers K; St George-Hyslop P; Van Broeckhoven C; Rogaeva E
    Neurobiol Aging; 2012 Dec; 33(12):2949.e5-2949.e12. PubMed ID: 22819390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
    Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
    Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.
    Klop B; van der Pol P; van Bruggen R; Wang Y; de Vries MA; van Santen S; O'Flynn J; van de Geijn GJ; Njo TL; Janssen HW; de Man P; Jukema JW; Rabelink TJ; Rensen PC; van Kooten C; Cabezas MC
    J Biol Chem; 2014 Dec; 289(51):35421-30. PubMed ID: 25349208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement receptor 1 genetic polymorphism contributes to sporadic Alzheimer's disease susceptibility in Caucasians: a meta-analysis.
    Yuan H; Du L; Ge P
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32432316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
    Pedraza O; Allen M; Jennette K; Carrasquillo M; Crook J; Serie D; Pankratz VS; Palusak R; Nguyen T; Malphrus K; Ma L; Bisceglio G; Roberts RO; Lucas JA; Ivnik RJ; Smith GE; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
    Alzheimers Dement; 2014 Mar; 10(2):205-13. PubMed ID: 23643458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer's disease.
    Zhu XC; Dai WZ; Ma T
    BMC Med Genet; 2020 Sep; 21(1):181. PubMed ID: 32919460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.
    Cockburn IA; Rowe JA
    Int J Immunogenet; 2006 Feb; 33(1):17-20. PubMed ID: 16426237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria.
    Teeranaipong P; Ohashi J; Patarapotikul J; Kimura R; Nuchnoi P; Hananantachai H; Naka I; Putaporntip C; Jongwutiwes S; Tokunaga K
    J Infect Dis; 2008 Dec; 198(12):1880-91. PubMed ID: 18954261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.